Tilak Mandadi - Aug 31, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Technology Officer
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Aug 31, 2023
Transactions value $
-$850,664
Form type
4
Date filed
9/1/2023, 04:22 PM
Previous filing
Apr 4, 2023
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$851K -13.1K -39.22% $65.17 20.2K Aug 31, 2023 Direct F1
holding CVS Common Stock (RSU) 66.6K Aug 31, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 96.5K Aug 31, 2023 Common Stock 96.5K $74.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
F2 Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.